[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100588757":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":10,"centralContacts":20,"locations":26,"responsibleParty":45,"collaborators":10,"id":47,"slug":10,"hasResults":48,"nctId":49,"briefTitle":50,"officialTitle":50,"acronym":51,"eligibilityCriteria":52,"healthyVolunteers":48,"sex":53,"minAge":54,"maxAge":10,"enrollmentInfo":55,"targetDuration":10,"studyType":58,"phases":10,"briefSummary":59,"conditions":60,"keywords":64,"overallStatus":29,"whyStopped":10,"lastUpdateSubmitDate":68,"lastUpdatePostDateStruct":69,"startDateStruct":72,"completionDateStruct":74,"leadSponsor":76,"locationsCount":77},{"fullName":5,"class":6},"Daping Hospital and the Research Institute of Surgery of the Third Military Medical University","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"IBD patient group",null,"Patients diagnosed with IBD according to clinical, imaging, endoscopic, and histopathological criteria.",[13],"Diagnostic Test: 18F-FAPI PET Imaging",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":10},"DIAGNOSTIC_TEST","18F-FAPI PET Imaging","The ROI of the target lesions was delineated based on 18F-FAPI PET Imaging, and the lesions were divided on the cross section to obtain the lesions SUVmax, SUVmean, SUVpeak, FAPI metabolic volume (FAV), MTV, TBR, and TLG.",[9],[21],{"name":22,"role":23,"phone":24,"phoneExt":10,"email":25},"Wenbo Li, postgraduate","CONTACT","+8615292886778","lwb@tmmu.edu.cn",[27],{"facility":28,"status":29,"city":30,"state":31,"zip":32,"country":33,"cosmosGeoPoint":34,"geoPoint":39,"contacts":40},"Army Medical Center of PLA, Daping Hospital, Army Medical University","RECRUITING","Chongqing","Chongqing Municipality","400042","China",{"type":35,"coordinates":36},"Point",[37,38],106.55771,29.56026,{"lat":38,"lon":37},[41,43],{"name":42,"role":23,"phone":24,"phoneExt":10,"email":25},"Wenbo Li",{"name":44,"role":23,"phone":10,"phoneExt":10,"email":10},"Li",{"type":46,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100588757",false,"NCT06945549","Evaluation of Intestinal Lesions and Disease Activity in Inflammatory Bowel Disease Based on 18F-FAPI PET Imaging","IBD，18F-FAPI","Inclusion Criteria:\n\n* Patients diagnosed with IBD according to clinical, imaging, endoscopic, and histopathological criteria;\n* Patients ≥18 years old;\n* 18F-FAPI PET\u002FCT intestinal imaging, conventional endoscopic and enhanced CT were performed within 1 week;\n* Intestinal segment matching was evaluated by endoscopy and imaging;\n* Patients voluntarily participate and sign informed consent.\n\nExclusion Criteria:\n\n* Pregnant or lactating patients;\n* Imaging images are of poor quality and cannot be used for diagnosis and evaluation;\n* Patients with contraindications for endoscopic or CT examination.","ALL","18 Years",{"count":56,"type":57},30,"ESTIMATED","OBSERVATIONAL","The goal of this observational study is to evaluate the role and effect of 18F-FAPI PET imaging in the identification of intestinal lesions and the assessment of disease activity in inflammatory bowel disease. The main question it aims to answer is:\n\nCan 18F-FAPI PET imaging effectively identify intestinal lesions in inflammatory bowel disease and accurately assess disease activity? Colonoscopy, enhanced abdominal CT, and 18F-FAPI intestinal imaging were completed within 1 week, and major adverse outcomes (MAO) were followed up 12 months after enrollment.\n\nLast updated on March 25, 2025",[61,62,63],"Inflammatory Bowel Disease (IBD)","Disease Activity","FAPI",[65,66,67],"Inflammatory bowel disease","18F-FAPI PET","disease activity","2025-06-25",{"date":70,"type":71},"2025-06-29","ACTUAL",{"date":73,"type":71},"2025-04-25",{"date":75,"type":57},"2027-12-31",{"name":5,"class":6},1]